ARS Pharmaceuticals, Inc. SPRY Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from ARS Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s free cash flow margin?
- ARS Pharmaceuticals, Inc. (SPRY) reported free cash flow margin of -177.1% in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s free cash flow margin changed year-over-year?
- ARS Pharmaceuticals, Inc.'s free cash flow margin decreased by 717.0% year-over-year, from -21.7% to -177.1%.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s free cash flow margin?
- Over 3 years (2022 to 2025), ARS Pharmaceuticals, Inc.'s free cash flow margin has grown at a -59.5% compound annual growth rate (CAGR), from -3,060.6% to -203.1%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.